Coral develops clinical tests that streamline the prior authorization process for healthcare providers by identifying the most effective medications for patients. This approach reduces administrative burdens and enhances treatment efficiency, ultimately improving patient outcomes.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare providers face significant administrative overhead navigating the prior authorization process for medications, leading to delays in patient access to necessary treatments. Determining the most effective medication for a patient often involves trial and error, further prolonging the process and potentially impacting patient outcomes.
Solution
Coral aims to streamline the medication prior authorization process by providing clinical tests that help healthcare providers identify the most effective medications for individual patients. By offering data-driven insights into medication efficacy, Coral reduces the need for trial-and-error prescribing, accelerating the approval process and improving treatment efficiency. This approach minimizes administrative burdens for providers, allowing them to focus on patient care and ultimately leading to better patient outcomes through more targeted and timely medication selection.
Target Audience
Coral's primary customers are healthcare providers, including physicians, hospitals, and clinics, seeking to optimize medication selection and reduce administrative burdens associated with prior authorizations.
Features
- Clinical tests designed to predict individual patient response to specific medications.
- Data-driven insights to inform medication selection and improve treatment efficacy.
- Streamlined prior authorization process through evidence-based medication recommendations.